Monday, October 03, 2022 10:08:55 AM
So why did Koos leave his so called golden child biotech REGEN if it has such important IP?
No one seems to want to answer that and, of course, Koos never explained his reasoning to his shareholders.
And talking about communicating to his shareholders, where is Koos doing that? Last communication was back in Decembers with his laundry list of things he was going to do, like hire a CSO. That hasn't happened. Nor has he released that white paper that he paid his brother $117,000 to write.
Why hasn't it been released?
FACTS are stubborn things
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM